Ipca Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,642.30
-12.1 (-0.73%)
BSENSE

May 20

BSE+NSE Vol: 1.43 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,642.30",
    "chg": -12.1,
    "chgp": "-0.73%",
    "dir": -1,
    "prev_price": "1,654.40",
    "mcapval": "41,665.84 Cr",
    "mcap": "Mid Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE571A01038",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "1.43 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1679.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-new-52-week-high-at-rs167945-4000919",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_priceRelatedfactors_4000919.png",
        "date": "2026-05-20 10:37:20",
        "description": "With a steady climb over the past five sessions delivering a near 10% gain, Ipca Laboratories Ltd surged to a fresh 52-week high of Rs 1679.45 on 20 Jun 2026, outpacing the broader market’s subdued performance and signalling robust price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1662",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-new-52-week-high-at-rs1662-3998573",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_priceRelatedfactors_3998573.png",
        "date": "2026-05-19 09:40:00",
        "description": "With a steady four-day gain culminating in a 9.43% rise, Ipca Laboratories Ltd has surged to a fresh 52-week high of Rs 1662 on 19 Jun 2026, outperforming the Sensex which remains subdued below its 50-day moving average."
      },
      {
        "title": "MarketsMOJO Upgrades Ipca Laboratories Ltd to Buy on Strong Technical and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marketsmojo-upgrades-ipca-laboratories-ltd-to-buy-on-strong-technical-and-financial-metrics-3998336",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_mojoScore_3998336.png",
        "date": "2026-05-19 08:38:33",
        "description": "Ipca Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements in its technical indicators, valuation metrics, financial trends, and overall quality. The pharmaceutical company’s stock has demonstrated robust price momentum and solid fundamentals, prompting a reassessment of its investment appeal by MarketsMOJO analysts."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1656.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-new-52-week-high-at-rs16561-3997067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_priceRelatedfactors_3997067.png",
        "date": "2026-05-18 13:35:13",
        "description": "With a decisive break above Rs 1656.1 on 18 Jun 2026, Ipca Laboratories Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-3996094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_technicaldot_3996094.png",
        "date": "2026-05-18 08:02:42",
        "description": "Ipca Laboratories Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by robust price action, positive signals from key technical indicators such as MACD and moving averages, and a strong relative performance against the Sensex over multiple timeframes."
      },
      {
        "title": "Ipca Laboratories Ltd Valuation Shifts Amidst Market Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-amidst-market-outperformance-3996059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_valuationdot_3996059.png",
        "date": "2026-05-18 08:02:22",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. Despite this, the stock has delivered robust returns over multiple time horizons, outperforming the Sensex significantly. This article analyses the recent valuation changes, compares Ipca Labs with its peers, and assesses the implications for investors amid evolving market dynamics."
      },
      {
        "title": "Ipca Laboratories Gains 3.48%: 3 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-348-3-key-factors-driving-the-weeks-rally-3994457",
        "imagepath": "",
        "date": "2026-05-16 14:04:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 11:</strong> Stock opens at Rs.1,533.30 amid downgrade to Hold</p>\n                    <p><strong>May 14:</strong> Intraday surge of 5.57% to Rs.1,590 signals strong rebound</p>\n                    <p><strong>May 15:</strong> New 52-week high of Rs.1,625 achieved</p>\n                    <p><strong>May 15:</strong> Week closes at Rs.1,605.75, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,551.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,605.75</di..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1625",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-new-52-week-high-at-rs1625-3992281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_priceRelatedfactors_3992281.png",
        "date": "2026-05-15 09:43:01",
        "description": "With a decisive surge to Rs 1625 on 15 Jun 2026, Ipca Laboratories Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market."
      },
      {
        "title": "Ipca Laboratories Ltd Surges 5.57% to Day's High of Rs 1590 — Outperforms Sector by 3.2 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-hits-intraday-high-with-557-surge-on-14-may-2026-3991431",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_priceRelatedfactors_3991431.png",
        "date": "2026-05-14 15:31:00",
        "description": "The Sensex advanced 1.18% on 14 Jun 2026, yet Ipca Laboratories Ltd outpaced the broader market with a 5.57% gain, reaching an intraday high of Rs 1590. This 3.2-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.37% rise highlights a distinctly stock-specific rally rather than a general market lift."
      }
    ],
    "total": 964,
    "sid": "950228",
    "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend",
      "datetime": "04-May-2026",
      "details": "Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Standalone and Consolidated Financial Results for 4th quarter and financial year ended 31st March 2026 and Dividend",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "The Company has enclosing herewith certificate received from RTA under reg 74 (5) of DP Regulations for the quarter ended 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Apr-2026",
      "details": "Newspaper Notice issued by the Company regarding transfer of physical shares.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "29 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25",
          "dt": "2025-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend

04-May-2026 | Source : BSE

Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Standalone and Consolidated Financial Results for 4th quarter and financial year ended 31st March 2026 and Dividend

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Apr-2026 | Source : BSE

The Company has enclosing herewith certificate received from RTA under reg 74 (5) of DP Regulations for the quarter ended 31.03.2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Apr-2026 | Source : BSE

Newspaper Notice issued by the Company regarding transfer of physical shares.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

29 May 2026

stock-summary
DIVIDEND

Ipca Laboratories Ltd has declared 200% dividend, ex-date: 05 Aug 25

stock-summary
SPLITS

Ipca Laboratories Ltd has announced 1:2 stock split, ex-date: 10 Jan 22

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available